test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KNSAKiniksa Pharmaceuticals International, Plc
Recent Activity
0.73%
$70.43M
2.818M shares@ $25.0 avg price
IGMSIgm Biosciences, Inc.
Recent Activity
Increased 0.05%
0.71%
$67.687M
4.092M shares@ $16.54 avg price
ARGXArgenx Se
Recent Activity
0.63%
$60.661M
111,904 shares@ $542.08 avg price
STOKStoke Therapeutics, Inc.
Recent Activity
0.56%
$53.688M
4.368M shares@ $12.29 avg price
IMCRImmunocore Holdings Plc
Recent Activity
0.49%
$47.172M
1.515M shares@ $31.13 avg price
KODKodiak Sciences Inc.
Recent Activity
0.47%
$45.18M
17.31M shares@ $2.62 avg price
SERASera Prognostics, Inc.
Recent Activity
0.44%
$42.388M
5.434M shares@ $7.8 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
Increased 743.08%
0.42%
$39.608M
843,075 shares@ $46.99 avg price
XENEXenon Pharmaceuticals Inc.
Recent Activity
0.41%
$39.121M
993,679 shares@ $39.37 avg price
IMVTImmunovant, Inc.
Recent Activity
Increased 163.69%
0.37%
$34.936M
1.225M shares@ $28.51 avg price